Titan Bio-Tech MD, chairman and AGM
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 29 Oct 2026. Previous close ₹352.00.
29 Oct: open ₹356.15, high ₹365.00, low ₹346.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,862 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 10.25
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.11%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 67,921
Titan Bio-Tech's chairperson is ROHIT JAIN, its managing director NARESH KUMAR SINGLA and its managing director SURESH CHAND SINGLA, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 29 Sep 2026.
Titan Bio-Tech board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Managing directorNARESH KUMAR SINGLA
- Managing directorSURESH CHAND SINGLA
- ChairpersonROHIT JAIN
- Company Secretary and Compliance OfficerCharanjit Singh
12 directors5 independent5 executive2 non-executive
- NARESH KUMAR SINGLA · Managing directorExecutive · joined May 2002 · reappointed Sep 2025 · 2 listed boards · 2 committee seats
- SURESH CHAND SINGLA · Managing directorExecutive · joined Oct 2006 · reappointed Sep 2025 · 2 listed boards · 3 committee seats
- MANJU SINGLANon-executive · joined Jun 2001 · reappointed Jun 2023 · 2 listed boards · 1 committee seat
- SUPRIYA SINGLANon-executive · joined Oct 2012 · reappointed Sep 2024 · 1 listed board
- ROHIT JAIN · ChairpersonIndependent · joined Jul 2021 · reappointed Sep 2026 · 60 months as independent · 1 listed board · 1 as independent
- ABHISHEK AGARWALIndependent · joined Oct 2022 · 48 months as independent · 1 listed board · 1 as independent · 1 committee seat
- RAJA SINGLAExecutive · joined Oct 2022 · reappointed Sep 2023 · 1 listed board
- DHAIRYA MADANIndependent · joined Oct 2023 · 36 months as independent · 1 listed board · 1 as independent · 1 committee seat
- UDIT SINGLAExecutive · joined Oct 2023 · 1 listed board
- SHIVOM SINGLAExecutive · joined Oct 2023 · 1 listed board
- BRIJESH KUMAR SINGHIndependent · joined Oct 2023 · 36 months as independent · 1 listed board · 1 as independent · 2 committee seats
- DEBENDRA KUMAR SABATIndependent · joined Aug 2025 · 13 months as independent · 1 listed board · 1 as independent · 2 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 3 Sep 20268 of 12 present5 independent · 20 days in between
- 13 Aug 202610 of 12 present3 independent · 42 days in between
- 1 Jul 20269 of 12 present2 independent · 31 days in between
- 30 May 202610 of 12 present5 independent · 53 days in between
1 earlier meeting
- 6 Apr 202611 of 12 present5 independent
Audit Committee
Chair ROHIT JAIN
MANJU SINGLA, ABHISHEK AGARWAL, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT
- 3 Sep 20265 of 5 present4 independent · 20 days in between
- 13 Aug 20263 of 5 present2 independent · 74 days in between
- 30 May 20265 of 5 present4 independent
Nomination and remuneration committee
Chair ABHISHEK AGARWAL
MANJU SINGLA, ROHIT JAIN, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT
- 3 Sep 20265 of 5 present4 independent · 149 days in between
- 6 Apr 20265 of 5 present4 independent
Stakeholders Relationship Committee
Chair ROHIT JAIN
SURESH CHAND SINGLA, NARESH KUMAR SINGLA, DHAIRYA MADAN, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT
- 3 Sep 20265 of 6 present4 independent · 63 days in between
- 1 Jul 20263 of 6 present1 independent · 31 days in between
- 30 May 20266 of 6 present4 independent · 53 days in between
- 6 Apr 20266 of 6 present4 independent
Corporate Social Responsibility Committee
Chair ROHIT JAIN
NARESH KUMAR SINGLA, ABHISHEK AGARWAL, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT
- 3 Sep 20264 of 5 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- A N S K & AssociatesPeer-review certificate valid to Apr 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Titan Bio-Tech AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Titan Bio-Tech dividend history
Annual general meeting, 29 Sep 2026
19,666 shareholders on the register on 22 Sep 2026; present: 10 promoters and 246 others; votes counted by PANKAJ KUMAR GUPTA / PKG & ASSOCIATES.The company's voting result
- Adoption of Audited Financial Statements (Standalone and Consolidated) for the financial year ended 31 March 2026 and the report of Auditors and Directors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
- Declaration of Dividend on Equity SharesOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
- Reappointment of Ms. Supriya Singla as Director, liable to retire by rotationOrdinaryPromoters have an interest in it99.67% for0.33% against
Against: promoters 0.00% · institutions 0.00% · other public 30.92%
Turnout: all 52.94% · promoters 93.90% · institutions 0.00% · other public 1.28%
- Reappointment of Mr. Shivom Singla as director liable to retire by rotationOrdinaryPromoters have an interest in it99.68% for0.32% against
Against: promoters 0.00% · institutions 0.00% · other public 12.91%
Turnout: all 54.63% · promoters 95.50% · institutions 0.00% · other public 3.07%
- Increase in the Authorised Share Capital of Company and Alteration of Capital Clause of Memorandum of Association of CompanyOrdinary99.69% for0.31% against
Against: promoters 0.00% · institutions 0.00% · other public 12.91%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
- Issue of Bonus Equity SharesOrdinary99.69% for0.31% against
Against: promoters 0.00% · institutions 0.00% · other public 12.91%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
- Authorisation for Loans etcSpecialPromoters have an interest in it99.65% for0.35% against
Against: promoters 0.00% · institutions 0.00% · other public 30.92%
Turnout: all 50.43% · promoters 89.39% · institutions 0.00% · other public 1.28%
- Ratification of remuneration to Cost Auditor for Financial Year 2026-27Ordinary99.69% for0.31% against
Against: promoters 0.00% · institutions 0.00% · other public 13.01%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
- Mortgage of Property of Company for borrowing funds and permission under Section 180(1) (a) of Companies Act, 2013Special99.69% for0.31% against
Against: promoters 0.00% · institutions 0.00% · other public 12.91%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
- Reappointment of Mr. Rohit Jain as independent director of company from 30-09-2026 for 5 yearsSpecial99.69% for0.31% against
Against: promoters 0.00% · institutions 0.00% · other public 12.91%
Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.